BioVasc Inc.

No Reviews Yet
No Completed Orders
San Francisco, California, US

About BioVasc Inc.

BioVasc Inc. is a clinical development consultancy, accelerator and startup incubator for emerging BioPharma|Biotech|Medtech|Nutratech companies.

Many biomedical startups are seeking to rapidly obtain robust, meaningful clinical data on their technologies, greatly enhancing their valuations, without breaking the bank (we speak Startups!). Services include protocol development and active study execution for human proof of concept (POC) and first-in-human (FIH) studies, alignment of preclinical and nonclinical studies to support FIH (we speak Science!), execution of active phase clinical studies, and safety and medical monitoring of human studies (we speak Clinical!). Cross-coordination with other functions including regulatory affairs, data management, business development and other key project stakeholders for harmonization of objectives.

Our Services (3)


Clinical Trials, Consulting, and Management

Price on request

Special expertise in preclinical, translational and clinical development of new therapeutic products (biomolecules, small molecule drugs and medical devices), with notable expertise at the opportunity-rich convergence of biopharma & medical devices.

Toxicology Drug Discovery First-in-human (FIH) Studies Clinical Trials Human Aging Cardiovascular Metabolism and Endocrinology Pain Genomics Biology CNS/Neurology Bioavailability Studies bioactivity testing bioassay Biomarker analysis Human tissue Blood drug safety adverse events treatment-emergent adverse events (TEAE) medical device Clinical Research Pharmacology Neuroscience Microbiome studies cGMP for early phase clinical trials biomarkers Dermatology Respiratory Metabolic Disease Show 31 more tags Show less


Clinical Development Strategy

Price on request

Protocol development and design:  I speak science (molecular pharmacology background) and engineering (med device experience), facilitating meaningful interfaces with preclinical and nonclinical R&D teams for effective translation to human POC studies.


Pharmaceutical Due Diligence

Price on request
Request a quote for more information about this service.

Not finding what you're looking for?

Get info on this provider's capabilities without requesting a quote.

Ken Colley MD|PhD

Chief Medical Officer

BioVasc Inc. has not received any reviews.

BioVasc Inc. has not received any endorsements.